Home Infusion Therapy Market growing at 9.0% from 2017 to 2024

U.S. Home Infusion Therapy Market size, By Product, 2013-2024
(USD Million)
Browse key industry insights spread across 95 pages with 52 market data tables & 9
figures & charts from the report Home Infusion Therapy Market in detail along with
the table of contents:
https://www.gminsights.com/industry-analysis/home-infusion-therapy-market-report
Meanwhile, it would be well advised to take note of the anticipated challenges that
might affect the home infusion therapy industry in the upcoming time period. The
industry has been marred by the haphazard, inadequate and complex
reimbursement system that has negatively impacted business growth. Add to it, the
inappropriate use of infusion therapy devices and improper dose administration
might severely hamper the growth potential of home infusion therapy industry.
Regionally, the U.S. home infusion therapy market is expected to gain commendable
momentum over the forecast period, owing to the presence of prominent industry
players complemented with increasing demand for homecare facilities, simplified
access to healthcare, and suitable reimbursement policies. Speaking along similar
lines, the UK home infusion therapy industry, especially Germany, stands to gain
noteworthy benefits as the advancing infusion devices and their increased usage in
pain management has been encouraging.
The home infusion therapy market is spanned by highly aggressive companies such
as Smiths Medical, Carefusion, Baxter, ICU Medical, JMS, Terumo, Caesarea
Medical Electronics, Fresenius Kabi, B.Braun Melsungen, to name a few. The
predominant industry players have coupled their product innovations and
technological advancements with robust mergers and alliances to form a strong
framework to accentuate sustained growth and expand the customer base. Citing an
instance, the world’s preeminent pure-play infusion firm, ICU Medical Inc., has
recently wrapped up its acquisition of Hospira Infusion Systems business from Pfizer
2 | P a g e